CJC-1295 DAC 5 mg

Dragon Pharma CJC-1295 DAC 5 mg is a lyophilized peptide product containing 5 mg of CJC-1295 DAC per vial. It is supplied in a 2 mL vial for research purposes.

DAC stands for Drug Affinity Complex, a chemical modification that binds to albumin in the bloodstream to slow clearance of the peptide, extending its duration of action compared with non-DAC versions.

The primary difference is the presence of the Drug Affinity Complex (DAC). CJC-1295 DAC has a longer duration of action, while CJC-1295 No DAC has a shorter half-life. These products are not interchangeable.

Each vial contains a labeled strength of 5 mg of CJC-1295 DAC.

The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.

Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.

Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.

Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.

Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy CJC-1295 DAC with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.

Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.

Growth hormone-releasing peptides, including CJC-1295, are prohibited under anti-doping rules in tested sport unless an applicable therapeutic-use exemption has been granted. Current requirements should be checked against the relevant anti-doping rules before competition.

Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.